During the past decade, Morgantown Internal Medicine Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Morgantown Internal Medicine Group" #1 sponsor was "Amgen" with 1 trials, followed by "Dartmouth-Hitchcock Medical Center" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Genta Incorporated" with 1 trials sponsored and "Mucosal Therapeutics" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Morgantown Internal Medicine Group" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Morgantown Internal Medicine Group" are "Lung Cancer" (2 trials), "Non-small Cell Lung Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Cardiac Arrhythmia" (1 trials) and "Fainting" (1 trials). Many other conditions were trialed in "Morgantown Internal Medicine Group" in a lesser frequency.

Most popular intervention types in "Morgantown Internal Medicine Group" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "docetaxel" (2 trials), "Erlotinib (tarceva)" (1 trials), "Placebo" (1 trials), "SNX-1012 (meclocycline sulfosalicylate)" (1 trials) and "Troxatyl™ (troxacitabine)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Morgantown Internal Medicine Group" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Morgantown Internal Medicine Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Morgantown Internal Medicine Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Morgantown Internal Medicine Group, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".